Korean J Sports Med.  2020 Sep;38(3):164-170. 10.5763/kjsm.2020.38.3.164.

Association between Relative Handgrip Strength and C-Reactive Protein in Adults

• Park DY
• Kang MS
• Park JY
• Kim MK
• Choi BY
• Kim YS

• KMID: 2506074
• DOI: http://doi.org/10.5763/kjsm.2020.38.3.164

Abstract

Purpose
The purpose of this study was to investigate whether obesity indicators are mediated in the association between muscle strength and inflammation levels, and further confirm the association between muscle strength level by sex and age and inflammatory levels.
Methods
In this study, 3,234 adults living in rural areas were surveyed from 2007 to 2015 and the data was finally analyzed on 2,149 adults. To identify that obesity indicators are mediated in relation to the association between relative grip strength and C-reactive protein (CRP) level, odds ratio (OR) and 95% confidence interval (CI) were calculated using logistic regression analysis (p＜ 0.05).
Results
As confounding variables were adjusted, the odds ratio for high inflammatory conditions was lower at a high (OR, 0.58; 95% CI, 0.40–0.85) or medium (OR, 0.64; 95% CI, 0.46–0.90) level of relative grip strength than a low level of relative grip strength. However, there were no significant results if the body fat percentage was added for the confounding variable. When the association between relative grip strength and inflammatory conditions was divided by sex, for women, the odds ratio about high inflammatory conditions was gradually decreased as the relative grip level increased (medium level: OR, 0.55; 95% CI, 0.35–0.87; high level: OR, 0.49; 95% CI, 0.30–0.82). The association of relative grip strength with inflammatory conditions was shown differently in age groups.
Conclusion
In conclusion, improvement of muscle strength is a factor that can lower the level of inflammation, and it is important to lower the level of inflammation that can cause cardiovascular disease through resistance exercise differentiated by age and sex.

Keyword

Aged; C-reactive protein; Inflammation hand strength

Reference

1. Liuzzo G, Biasucci LM, Gallimore JR, et al. 1994; The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina. N Engl J Med. 331:417–24. DOI: 10.1056/NEJM199408183310701. PMID: 7880233.

2. Rifai N, Ridker PM. 2001; High-sensitivity C-reactive protein: a novel and promising marker of coronary heart disease. Clin Chem. 47:403–11. DOI: 10.1093/clinchem/47.3.403. PMID: 11238289.

3. Pepys MB, Hirschfield GM. 2003; C-reactive protein: a critical update. J Clin Invest. 111:1805–12. DOI: 10.1172/JCI200318921. PMID: 12813013. PMCID: PMC161431.

4. Packard RR, Libby P. 2008; Inflammation in atherosclerosis: from vascular biology to biomarker discovery and risk prediction. Clin Chem. 54:24–38. DOI: 10.1373/clinchem.2007.097360. PMID: 18160725.

5. Shrivastava AK, Singh HV, Raizada A, Singh SK. 2015; C-reactive protein, inflammation and coronary heart disease. Egypt Heart J. 67:89–97. DOI: 10.1016/j.ehj.2014.11.005.

6. Volaklis KA, Halle M, Koenig W, et al. 2015; Association between muscular strength and inflammatory markers among elderly persons with cardiac disease: results from the KORA-Age study. Clin Res Cardiol. 104:982–9. DOI: 10.1007/s00392-015-0867-7. PMID: 25967155.

7. Smith JK, Dykes R, Douglas JE, Krishnaswamy G, Berk S. 1999; Long-term exercise and atherogenic activity of blood mononuclear cells in persons at risk of developing ischemic heart disease. JAMA. 281:1722–7. DOI: 10.1001/jama.281.18.1722. PMID: 10328073.

8. Yudkin JS, Stehouwer CD, Emeis JJ, Coppack SW. 1999; C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol. 19:972–8. DOI: 10.1161/01.ATV.19.4.972. PMID: 10195925.

9. Stenholm S, Sallinen J, Koster A, et al. 2011; Association between obesity history and hand grip strength in older adults: exploring the roles of inflammation and insulin resistance as mediating factors. J Gerontol A Biol Sci Med Sci. 66:341–8. DOI: 10.1093/gerona/glq226. PMID: 21310808. PMCID: PMC3041473.

10. Danesh J, Muir J, Wong YK, Ward M, Gallimore JR, Pepys MB. 1999; Risk factors for coronary heart disease and acute-phase proteins: a population-based study. Eur Heart J. 20:954–9. DOI: 10.1053/euhj.1998.1309. PMID: 10361047.

11. Lawman HG, Troiano RP, Perna FM, Wang CY, Fryar CD, Ogden CL. 2016; Associations of relative handgrip strength and cardiovascular disease biomarkers in U.S. adults, 2011-2012. Am J Prev Med. 50:677–83. DOI: 10.1016/j.amepre.2015.10.022. PMID: 26689977. PMCID: PMC7337414.

12. Bassuk SS, Rifai N, Ridker PM. 2004; High-sensitivity C-reactive protein: clinical importance. Curr Probl Cardiol. 29:439–93. DOI: 10.1016/S0146-2806(04)00074-X. PMID: 15258556.

13. Raison CL, Rutherford RE, Woolwine BJ, et al. 2013; A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers. JAMA Psychiatry. 70:31–41. DOI: 10.1001/2013.jamapsychiatry.4. PMID: 22945416. PMCID: PMC4015348.

14. Eknoyan G, Lameire N, Eckardt K, et al. 2013; KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int. 3:5–14.

15. Koenig W, Sund M, Frohlich M, et al. 1999; C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992. Circulation. 99:237–42. DOI: 10.1161/01.CIR.99.2.237. PMID: 9892589.

16. Pedersen BK. 2011; Muscles and their myokines. J Exp Biol. 214(Pt 2):337–46. DOI: 10.1242/jeb.048074. PMID: 21177953.

17. Olson TP, Dengel DR, Leon AS, Schmitz KH. 2007; Changes in inflammatory biomarkers following one-year of moderate resistance training in overweight women. Int J Obes (Lond). 31:996–1003. DOI: 10.1038/sj.ijo.0803534. PMID: 17299382.

18. Bohannon RW. 2015; Muscle strength: clinical and prognostic value of hand-grip dynamometry. Curr Opin Clin Nutr Metab Care. 18:465–70. DOI: 10.1097/MCO.0000000000000202. PMID: 26147527.

19. Shimokata H, Ando F, Yuki A, Otsuka R. 2014; Age-related changes in skeletal muscle mass among community-dwelling Japanese: a 12-year longitudinal study. Geriatr Gerontol Int. 14(Suppl 1):85–92. DOI: 10.1111/ggi.12219. PMID: 24450565.

20. Goodpaster BH, Park SW, Harris TB, et al. 2006; The loss of skeletal muscle strength, mass, and quality in older adults: the health, aging and body composition study. J Gerontol A Biol Sci Med Sci. 61:1059–64. DOI: 10.1093/gerona/61.10.1059. PMID: 17077199.

21. Hughes VA, Frontera WR, Roubenoff R, Evans WJ, Singh MA. 2002; Longitudinal changes in body composition in older men and women: role of body weight change and physical activity. Am J Clin Nutr. 76:473–81. DOI: 10.1093/ajcn/76.2.473. PMID: 12145025.

22. Rothenbacher D, Hoffmeister A, Brenner H, Koenig W. 2003; Physical activity, coronary heart disease, and inflammatory response. Arch Intern Med. 163:1200–5. DOI: 10.1001/archinte.163.10.1200. PMID: 12767957.

23. Lauretani F, Russo CR, Bandinelli S, et al. 2003; Age-associated changes in skeletal muscles and their effect on mobility: an operational diagnosis of sarcopenia. J Appl Physiol (1985). 95:1851–60. DOI: 10.1152/japplphysiol.00246.2003. PMID: 14555665.

24. Barbieri M, Ferrucci L, Ragno E, et al. 2003; Chronic inflammation and the effect of IGF-I on muscle strength and power in older persons. Am J Physiol Endocrinol Metab. 284:E481–7. DOI: 10.1152/ajpendo.00319.2002. PMID: 12419777.

25. Febbraio MA, Pedersen BK. 2002; Muscle-derived interleukin-6: mechanisms for activation and possible biological roles. FASEB J. 16:1335–47. DOI: 10.1096/fj.01-0876rev. PMID: 12205025.